Shu Hisata

1.7k total citations
24 papers, 918 citations indexed

About

Shu Hisata is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Shu Hisata has authored 24 papers receiving a total of 918 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in Shu Hisata's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers), Eosinophilic Disorders and Syndromes (3 papers) and Sarcoidosis and Beryllium Toxicity Research (3 papers). Shu Hisata is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers), Eosinophilic Disorders and Syndromes (3 papers) and Sarcoidosis and Beryllium Toxicity Research (3 papers). Shu Hisata collaborates with scholars based in Japan, United States and China. Shu Hisata's co-authors include Augustine M.K. Choi, Kiichi Nakahira, Toshihiro Nukiwa, Masahito Ebina, Suzanne M. Cloonan, Hiromitsu Ohta, Shinya Ohkouchi, Takashi Kondo, Masakazu Shinohara and Ziling Huang and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Shu Hisata

23 papers receiving 909 citations

Peers

Countries citing papers authored by Shu Hisata

Since Specialization

Citations

This map shows the geographic impact of Shu Hisata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Hisata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Hisata more than expected).

Fields of papers citing papers by Shu Hisata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu Hisata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Hisata. The network helps show where Shu Hisata may publish in the future.

Co-authorship network of co-authors of Shu Hisata

This figure shows the co-authorship network connecting the top 25 collaborators of Shu Hisata. A scholar is included among the top collaborators of Shu Hisata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu Hisata. Shu Hisata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A case of microscopic polyangiitis with interstitial pneumonia after coronavirus disease-2019 infection, evidenced by positivity for multiple autoantibodies 2024 ·Respiratory Medicine Case Reports ·N. Arai, (unknown), Masashi Bando, (unknown), (unknown), Shu Hisata, Makoto Maemondo	1
2	Significance of Persistent Systemic Support in the Clinical Course of Delayed Post-hypoxic Leukoencephalopathy Following Severe Coronavirus Disease 2019 2024 ·Internal Medicine ·(unknown), Naoko Mato, Hiroyuki Fujii, (unknown), (unknown), Shinshu Katayama, (unknown), (unknown), (unknown), (unknown), Shu Hisata, Shin Nunomiya, Koichi Hagiwara, Makoto Maemondo	0
3	Exploratory phase 2 study of the novel oral multi-kinase inhibitor TAS-115 in patients with idiopathic pulmonary fibrosis 2023 ·Respiratory Investigation ·Yasuhiko Nishioka, Sakae Homma, Takashi Ogura, Seidai Sato, (unknown), Keisuke Tomii, Koichiro Kamio, Susumu Sakamoto, Yasunari Miyazaki, Hiromi Tomioka, Shu Hisata, Tomohiro Handa, Arata Azuma	7
4	Patient-derived spheroids and patient-derived organoids simulate evolutions of lung cancer 2023 ·Heliyon ·(unknown), (unknown), (unknown), Shu Hisata, (unknown), Satomi Fujiwara, Fangyuan Liu, Noriyoshi Fukushima, Takuji Suzuki, Naoko Mato, Koichi Hagiwara	8
5	Safety and tolerability of combination therapy with pirfenidone and nintedanib for idiopathic pulmonary fibrosis: A multicenter retrospective observational study in Japan 2021 ·Respiratory Investigation ·Shu Hisata, Masashi Bando, Sakae Homma, Kensuke Kataoka, Takashi Ogura, Shinyu Izumi, Susumu Sakamoto, Kizuku Watanabe, Yoshinobu Saito, Yasuo Shimizu, Motoyasu Kato, Yasuhiko Nishioka, Hiromichi Hara, Yuko Waseda, Yoshinori Tanino, Kazuhiro Yatera, (unknown), Hiroshi Mukae, Naohiko Inase	17
6	Reversal of emphysema by restoration of pulmonary endothelial cells 2021 ·The Journal of Experimental Medicine ·Shu Hisata, Alexandra C. Racanelli, Pouneh Kermani, Ryan Schreiner, Sean Houghton, Brisa Palikuqi, Balvir Kunar, (unknown), (unknown), Allyson Capili, David Redmond, Daniel J. Nolan, Michael Ginsberg, Bi‐Sen Ding, Fernando J. Martínez, Joseph M. Scandura, Suzanne M. Cloonan, Shahin Rafii, Augustine M.K. Choi	50
7	NLRP3 Inflammasome Activation in Lung Vascular Endothelial Cells Contributes to Intestinal Ischemia/Reperfusion-Induced Acute Lung Injury 2020 ·The Journal of Immunology ·Homare Ito, Hiroaki Kimura, Tadayoshi Karasawa, Shu Hisata, Ai Sadatomo, Yoshiyuki Inoue, Naoya Yamada, Emi Aizawa, (unknown), Ryo Kamata, Takanori Komada, Sachiko Watanabe, Tadashi Kasahara, Takuji Suzuki, Hisanaga Horie, Joji Kitayama, Naohiro Sata, Kazuyo Yamaji-Kegan, Masafumi Takahashi	31
8	A case of lymphocytic interstitial pneumonia presenting with a ground glass nodule as an initial finding 2020 ·Respiratory Medicine Case Reports ·Makoto Kawaguchi, Masayuki Nakayama, Masashi Bando, Shu Hisata, Naoko Mato, Takuji Suzuki, Tamiko Takemura, Koichi Hagiwara	1
9	Mitofusins regulate lipid metabolism to mediate the development of lung fibrosis 2019 ·Nature Communications ·Kuei‐Pin Chung, Chia‐Lang Hsu, (unknown), Ziling Huang, Divya Bhatia, (unknown), Shu Hisata, Soo Jung Cho, Kiichi Nakahira, Mitsuru Imamura, Mary E. Choi, Chong‐Jen Yu, Suzanne M. Cloonan, Augustine M.K. Choi	131
10	Sequential Granulocyte-Macrophage Colony-Stimulating Factor Inhalation after Whole-Lung Lavage for Pulmonary Alveolar Proteinosis. A Report of Five Intractable Cases 2017 ·Annals of the American Thoracic Society ·Shinya Ohkouchi, Keiichi Akasaka, Toshio Ichiwata, Shu Hisata, Hideya Iijima, Toshinori Takada, Hiroki Tsukada, Hideaki Nakayama, (unknown), Toshiya Irokawa, Hiromasa Ogawa, Yoko Shibata, Masakazu Ichinose, Masahito Ebina, Toshihiro Nukiwa, Hájíme Kurosawa, Koh Nakata, Ryushi Tazawa	22
11	NLRP3 Inflammasome Deficiency Protects Against Microbial Sepsis Via Increased Lipoxin B4 Synthesis 2017 ·American Journal of Respiratory and Critical Care Medicine ·Seonmin Lee, Kiichi Nakahira, Jesmond Dalli, Ilias Ι. Siempos, Paul C. Norris, Romain A. Colas, Jong‐Seok Moon, Masakazu Shinohara, Shu Hisata, Judie A. Howrylak, Gee Young Suh, Stefan W. Ryter, Charles N. Serhan, Augustine M.K. Choi	131
12	The Roles of Mitochondrial Damage-Associated Molecular Patterns in Diseases 2015 ·Antioxidants and Redox Signaling ·Kiichi Nakahira, Shu Hisata, Augustine M.K. Choi	261
13	The Multicenter Study of a New Assay for Simultaneous Detection of Multiple Anti-Aminoacyl-tRNA Synthetases in Myositis and Interstitial Pneumonia 2014 ·PLoS ONE ·Ran Nakashima, Yoshitaka Imura, Yuji Hosono, (unknown), Akihiro Murakami, Kizuku Watanabe, Tomohiro Handa, Michiaki Mishima, Michito Hirakata, Tsutomu Takeuchi, Keishi Fujio, Kazuhiko Yamamoto, Hitoshi Kohsaka, Yoshinari Takasaki, Noriyuki Enomoto, Takafumi Suda, Kingo Chida, Shu Hisata, Toshihiro Nukiwa, Tsuneyo Mimori	93
14	Development of pulmonary alveolar proteinosis following exposure to dust after the Great East Japan Earthquake 2013 ·Respiratory Investigation ·Shu Hisata, Hiroshi Moriyama, Ryushi Tazawa, Shinya Ohkouchi, Masakazu Ichinose, Masahito Ebina	7
15	An ectopic ACTH-producing small cell lung carcinoma associated with enhanced corticosteroid biosynthesis in the peritumoral areas of adrenal metastasis 2012 ·Lung Cancer ·Hironori Satoh, Ryoko Saito, Shu Hisata, (unknown), (unknown), Yasuhiro Nakamura, Toshihiro Nukiwa, Masahito Ebina, Hironobu Sasano	3
16	The Diagnostic Value of the Interstitial Biomarkers KL-6 and SP-D for the Degree of Fibrosis in Combined Pulmonary Fibrosis and Emphysema 2012 ·Pulmonary Medicine ·Shigeki Chiba, Hiromitsu Ohta, (unknown), Shu Hisata, Shinya Ohkouchi, Yasushi Hoshikawa, Takashi Kondo, Masahito Ebina	20
17	Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis 2011 ·Pulmonary Medicine ·Masahito Ebina, Hiroyuki Taniguchi, Taku Miyasho, Shingo Yamada, Naoko Shibata, Hiromitsu Ohta, Shu Hisata, Shinya Ohkouchi, Tsutomu Tamada, Hidekazu Nishimura, Akitoshi Ishizaka, Ikuro Maruyama, Yoshinori Okada, Takashi Kondo, Toshihiro Nukiwa	50
18	The Disappearance of Subpleural and Interlobular Lymphatics in Idiopathic Pulmonary Fibrosis 2010 ·Lymphatic Research and Biology ·Masahito Ebina, Naoko Shibata, Hiromitsu Ohta, Shu Hisata, Tsutomu Tamada, Masao Ono, (unknown), Takashi Kondo, Toshihiro Nukiwa	35
19	A Normal Range of KL-6/MUC1 Independent of Elevated SP-D Indicates a Better Prognosis in the Patients with Honeycombing on High-Resolution Computed Tomography 2010 ·Pulmonary Medicine ·Shu Hisata, Yuichiro Kimura, Naoko Shibata, Shuichi Ono, Takao Kobayashi, Shigeki Chiba, Hiromitsu Ohta, Toshihiro Nukiwa, Masahito Ebina	16
20	Pirfenidone, A Novel Anti-fibrotic Agent, Provides Higher Benefit For Idiopathic Pulmonary Fibrosis (IPF) Patients With Better Pulmonary Function 2010 ·Masahito Ebina, Yuichiro Kimura, Hiromitsu Ohta, Shu Hisata, Tsutomu Tamada, Toshihiro Nukiwa	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact